Project Grant R21AG091331
Award Date
1/1/25
Completion Date
12/31/26
Dollars Obligated
$451K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $203,278 to Brandeis University from November 2024 to January 2026 to conduct research on the neurobiological mechanisms underlying daily life activity participation in older adults and its relationship to Alzheimer's disease pathology. The project will use a multilevel, multimodal framework including behavioral, psychophysiological, neuroimaging, and naturalistic approaches to understand...
This $208,750 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a research project titled "Characterizing Autonomic Impairments in Frontotemporal Dementia" at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The primary objectives are to: Assess the test-retest reliability of "gold-standard" measurements of autonomic function in 30 patients with behavioral variant frontotemporal...
This federal Project Grant award, totaling $198,355.00, was provided by the National Institute on Aging under the Aging Research grant program (CFDA 93.866) to The Johns Hopkins University. The primary objective is to conduct a Positron Emission Tomography (PET) study to measure changes in neural circuitry associated with affective symptoms (depression, anxiety, irritability, agitation) and cognitive deficits in patients with behavioral variant frontotemporal dementia (bvFTD). The research...
This Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,275,512 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the impact of progranulin species on TDP-43 proteolysis and pathobiology in neurodegenerative disorders such as Alzheimer's disease, frontotemporal dementia, and limbic-predominant, age-associated TDP-43 encephalopathy. The research aims to determine how progranulin species contribute to TDP-43...
This federal Project Grant award of $307,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct a single, highly powered study to identify memory processes that are most sensitive to the asymptomatic, preclinical stage of Alzheimer's disease (AD) pathology. The study combines a continuous report item-location associative memory task with advanced behavioral and neural modeling to estimate subtle changes in memory precision that may differentiate healthy...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $106,464 to Brandeis University to conduct research on the associations between monoamine neurotransmitter systems, tau pathology, and emotional memory in aging. The research will utilize positron emission tomography (PET) imaging techniques to measure monoamine synthesis capacity and tau pathology in the brain, and relate these measures to performance on an emotional memory task. The findings...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $2,398,069 Project Grant to The Trustees of the University of Pennsylvania for the project "Pathology-Guided Biofluid Biomarker Strategies for Classification and Progression of Frontotemporal Lobar Degeneration (FTLD)." The project aims to develop multi-analyte algorithms to screen for and provide prognosis of FTLD, a family of neurodegenerative proteinopathies, by...
This Federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $107,272 to Brandeis University to investigate the role of dopamine in reward memory processing in aging. The primary objectives are to: 1) Establish relationships between dopamine function and reward-related fMRI activation patterns during memory encoding, and 2) Link fMRI reinstatement, dopamine, and cognitive performance in older adults. The award period runs from Jan 3, 2025 to Jul...
This $562,314 federal Project Grant awarded by the National Institute on Aging under the Aging Research program (CFDA 93.866) supports a 3-year study to identify risk and protective factors associated with psychosocial resilience in spousal caregivers for spouses with Alzheimer's disease and related dementias. The study leverages data from several large, longitudinal cohort studies, including the Health and Retirement Study, to examine how caregivers' well-being, mental health, and cognitive...
This $630,496 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the J. David Gladstone Institutes in San Francisco, CA supports a research project titled "Proteostasis, Neuroinflammation and Neurodegeneration in Frontotemporal Dementia". The project aims to investigate the underlying mechanisms of proteostasis dysfunction and the link between glial cell activation, inflammation, and neurodegeneration in frontotemporal dementia caused by GRN...